Phylogenetic analysis of protease and transmembrane region of HIV type 1 group O

AIDS Research and Human Retroviruses

Volumn 16, Issue 11, 2000, Pages 1075-1081

  Yang, Chunfu ^a   Gao, Feng ^b   Fonjungo, Peter N ^a   Zekeng, Leopold ^c   Van Der Groen, Guido ^d   Pieniazek, Danuta ^a   Schable, Charles ^a   Lal, Renu B ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b and Clinical Center   (United States)

^c Laboratoire de Sante Hygiene Mobile   (Cameroon)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; BIODIVERSITY; CLINICAL ARTICLE; GENE CLUSTER; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; GENES, ENV; GENES, VIRAL; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV PROTEASE; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ANALYSIS, DNA;

EID: 0034691741     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050075345     Document Type: Article

References (26)

1. 1. Carr JK, Foley BT, Leitner T, Salminen M, Korber B, and McCutchan F: Reference sequences representing the principal genetic diversity of HIV-1 in the pandemic. In: Human Retroviruses and AIDS - 1998 (Korber B, Kuiken C, Foley B, Hahn B, McCutchan F, Mellors J, and Sodroski J, eds.). Los Alamos National Laboratory, Los Alamos, New Mexico, 1998, pp. III10-III19.
2. 2. Simon F, Mauclere P, Roques P, et al.: Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nature Med 1998;4:1032-1037.
3. 3. Peeters M, Gueye A, Mboup S, et al.: Geographical distribution of HIV-1 group O viruses in Africa. AIDS 1997;11:493-498.
4. 4. Loussert-Ajaka I, Chaix M-L, Korber B, et al.: Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol 1995;69:5640-5649.
5. 5. Hampl H, Sawitzky D, Stoffler-Meilicke M, et al.: First case of HIV subtype O infection in Germany. Infection 1995;23:369-370.
6. 6. Rayfield MA, Sullivan P, Bander CI, et al.: HIV-1 group O virus identified for the first time in the United States. Emerg Infect Dis 1996;2:209-212.
7. 7. Soriano V, Gutierrez M, Garcia-Lerma G, et al.: First case of HIV-1 group O infection in Spain. Vox Sang 1996;71:66.
8. 8. Schable C, Zekeng L, Pau C, et al.: Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994;344:1333-1334.
9. 9. Loussert-Ajaka I, Ly TD, Chaix ML, et al.: HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994;343: 1393-1394.
10. 10. Eberle J, Loussert-Ajaka I, Brust S, et al.: Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection. J Virol Methods 1997;67:85-91.
11. 24 protein and the C2V3 region of the envelope protein. In: Human Retroviruses and AIDS - 7996 (Myers G, Korber B, Foley B, Jeang K-T, Mellows JW, and Wain-Hobson S, eds.). Los Alamos National Laboratory, Los Alamos, New Mexico, 1996, pp. III41-III56.
12. 12. Bibollet-Ruche F, Peeters M, Mboup S, et al.: Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countries. AIDS Res Hum Retroviruses 1998;14: 1281-1285.
13. 13. Bibollet-Ruche F, Loussert-Ajaka I, Simon F, et al.: Genetic characterization of accessory genes from human immunodeficiency virus type 1 group O strains. AIDS Res Hum Retroviruses 1998;14:951-961.
14. 14. Quinones-Mateu M, Albright JL, Mas A, Soriano V, and Arts EJ: Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1. J Virol 1998;72:9002-9015.
15. 15. Mas A, Quinones-Mateu ME, Domingo E, and Soriano V: Phylogeny of HIV type 1 group O isolates based on env gene sequences. AIDS Res Hum Retroviruses 1999;15:769-773.
16. 16. Janssens W, Heyndrickx L, Van der Auwera G, et al.: Interpatient genetic variability of HIV-1 group O. AIDS 1999;13:41-48.
17. 17. Yang C, Pieniazek D, Owen SM, et al.: Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers. J Clin Microbiol 1999;37:2581-2586.
18. 18. Thompson JD, Higgins DG, and Gibson TJ: CLUSTALW: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
19. 19. Felsenstein J: PHYLIP - phylogeny interference package (version 3.2). Cladistics 1989;5:164-166.
20. 20. Jonassen T, Stene-Johansen K, Berg ES, et al.: Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s. Virology 1997;231:43-47.
21. 21. Sullivan PS, Do AN, Ellenberger D, et al.: Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States. J Infect Dis 2000;181:463-469.
22. 22. Dorn J, Masciotra S, Yang C, et al.: Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type (HIV-1) group M and its impact on HIV-1 antibody detection. J Clin Microbiol 2000;38: 773-780.
23. 23. Heyndrickx L, Alary M, Janssens W, Davo N, and van der Groen G: HIV-1 group O and group M dual infection in Benin. Lancet 1996;347:902-903.
24. 24. Takehisa J, Zekeng L, Miura T, et al.: Triple HIV-1 infection with group O and group M of different clades in a single Cameroonian AIDS patient. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:81-82.
25. 25. Takehisa J, Zekeng L, Ido E, et al.: Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon. J Virol 1999;73:6810-6820.
26. 26. Peeters M, Liegeois F, Torimiro N, et al.: Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol 1999;73:7368-7375.